OMEROS CORP (OMER)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for OMER
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| OMER | Chairman of the Board, President, Chief Executive Officer; CEO; Chairman of the Board | 67 | ["Founded the company","Served as president and chief executive officer since June 1994","Experience as chief financial officer and treasurer (interim capacity)","Experience as chief medical officer","Completed residency in orthopedic surgery at Stanford University","Fellowship training in hand and microvascular surgery at Duke University","Recipient of the Prix Galien Canada Research Award in 2019","Serves on the board of trustees of the Smead Funds Trust","M.D. from Stanford University School of Medicine","B.S. from Stanford University","Medical and scientific expertise","Experience with clinical development and design","Detailed knowledge of operations and development programs"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Gregory A. Demopulos, M.D., founded our company and has served as our president, chief executive officer and chairman of the board of directors since June 1994. He also served as our chief financial officer and treasurer from January 2009 to October 2013 in an interim capacity and as our chief medical officer from June 1994 to March 2010. Prior to founding Omeros, Dr. Demopulos completed his residency in orthopedic surgery at Stanford University and his fellowship training in hand and microvascular surgery at Duke University. In 2019, Dr. Demopulos was a recipient of the Prix Galien Canada Research Award. Dr. Demopulos currently serves on the board of trustees of the Smead Funds Trust, an open-end mutual fund company registered under the Investment Company Act of 1940. Dr. Demopulos received his M.D. from Stanford University School of Medicine and his B.S. from Stanford University. Dr. Demopulos qualifications to serve on the board of directors include his position and experience as our president and chief executive officer, his medical and scientific expertise, experience with clinical development and design and detailed knowledge of our operations and development programs. Dr. Demopulos is the brother of Peter A. Demopulos, M.D., a member of our board of directors.